Advance Search
GUO Linlin, XIE Lu, LIU Yongfang, LI Panpan, GUO Lin. Analysis of infection and related risk factors after heart transplantation in a third-grade class-A hospital from 2018 to 2023[J]. Journal of Clinical Medicine in Practice, 2024, 28(6): 104-107, 112. DOI: 10.7619/jcmp.20233393
Citation: GUO Linlin, XIE Lu, LIU Yongfang, LI Panpan, GUO Lin. Analysis of infection and related risk factors after heart transplantation in a third-grade class-A hospital from 2018 to 2023[J]. Journal of Clinical Medicine in Practice, 2024, 28(6): 104-107, 112. DOI: 10.7619/jcmp.20233393
shu

Analysis of infection and related risk factors after heart transplantation in a third-grade class-A hospital from 2018 to 2023

  • Department of Cardiac Surgery, the Seventh People's Hospital of Zhengzhou of Henan Province, Zhengzhou, Henan, 450000

More Information
  • Received Date: October 24, 2023
  • Revised Date: January 03, 2024
  • Available Online: April 01, 2024
    Graphical Abstract
    • Abstract
  • Objective 

    To investigate the infection status after heart transplantation (HT) in a third-grade class-A hospital from 2018 to 2023, and explore its risk factors.

    Methods 

    A retrospective analysis was conducted on the data of 314 patients who underwent HT surgery from January 2018 to July 2023, they were divided into infection group and control group according to postoperative infection situation, the possible influencing factors of HT postoperative infection were analyzed by univariate analysis, and the risk factors of HT postoperative infection were screened by multivariate Logistic regression analysis.

    Results 

    A total of 91 patients(28.98%)developed postoperative infections, with infection sites of respiratory tract and blood. Logistic regression analysis showed that the main risk factors for postoperative infection in HT patients included complicating with chronic lung disease, surgical time ≥5 h, long retention time of postoperative thoracic drainage tube, long postoperative urinary tube retention time, long postoperative mechanical ventilation time, and preoperative Alb < 35 g/L.

    Conclusion 

    Complicating chronic lung disease, surgical time ≥5 h, long postoperative thoracic drainage tube retention time, long postoperative urinary tube retention time, long postoperative mechanical ventilation time, preoperative Alb < 35 g/L are related to postoperative infection of HT. Therefore, active intervention should be carried out for the above factors in patients to reduce the risk of infection.

    • FullText(HTML)
    • References (21)
  • [1]
    ANTHONY C, IMRAN M, POULIOPOULOS J, et al. Cardiovascular magnetic resonance for rejection surveillance after cardiac transplantation[J]. Circulation, 2022, 145(25): 1811-1824. doi: 10.1161/CIRCULATIONAHA.121.057006
    [2]
    任悦, 刘晨晨, 吴玉红, 等. 免疫抑制剂导致非恶性血液病感染的防治策略[J]. 天津医科大学学报, 2022, 28(2): 222-225. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYK202202023.htm
    [3]
    GÓMEZ-LÓPEZ R, BARGE-CABALLERO E, FERNÁNDEZ-UGIDOS P, et al. In-hospital post-operative infection after heart transplantation: epidemiology, clinical management, and outcome[J]. Surg Infect, 2020, 21(2): 179-191. doi: 10.1089/sur.2019.073
    [4]
    刘云霏, 郭琳, 浮志坤, 等. 主动脉内球囊反搏对心脏移植术后围手术期感染的影响[J]. 实用医学杂志, 2023, 39(7): 844-848, 854. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ202307009.htm
    [5]
    中华人民共和国卫生部. 医院感染诊断标准(试行)[J]. 中华医学杂志, 2001, 81(5): 314-320.
    [6]
    中国疾病预防控制中心, 中国疾病预防控制中心慢性非传染性疾病预防控制中心. 中国慢性病及其危险因素监测报告-2010[M]. 北京: 军事医学科学出版社, 2012: 43-45.
    [7]
    NADZIAKIEWICZ P, GROCHLA M, KRAUCHUK A, et al. Procalcitonin kinetics after heart transplantation and as a marker of infection in early postoperative course[J]. Transplant Proc, 2020, 52(7): 2087-2090. doi: 10.1016/j.transproceed.2020.02.117
    [8]
    顾晓会, 盛丹, 邹萌, 等. 胃癌根治术后感染影响因素及NF-κB、MCP-1表达和肠道微生态与肠道屏障功能的关系[J]. 中华医院感染学杂志, 2023, 33(10): 1512-1516. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY202310016.htm
    [9]
    柴靖, 王豆豆, 王蛟, 等. 膝关节骨性关节炎患者术后感染病原菌分布耐药性以及影响因素分析[J]. 河北医学, 2023, 29(4): 617-622. https://www.cnki.com.cn/Article/CJFDTOTAL-HCYX202304017.htm
    [10]
    任珍平, 郭琳, 陈健超, 等. 心脏移植术后感染的危险因素分析及风险预测模型构建[J]. 上海医药, 2023, 44(9): 41-44. https://www.cnki.com.cn/Article/CJFDTOTAL-SYIY202309011.htm
    [11]
    李雪, 王高彪, 郭丽萍, 等. 儿童心脏移植术后耐碳青霉烯类肺炎克雷伯菌血流感染的治疗药物分析[J]. 上海医药, 2022, 43(7): 92-95. https://www.cnki.com.cn/Article/CJFDTOTAL-SYIY202207024.htm
    [12]
    袁婷, 邱贝丽, 李燕君, 等. 心脏移植受者术后首次住院期间获得性肺部感染和肺部感染死亡的危险因素分析[J]. 中国医药, 2020, 15(1): 41-44. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG202001012.htm
    [13]
    高非, 何茵, 鹿振辉, 等. 肺癌术后并发肺部感染的病原菌分布及影响因素的回顾性研究[J]. 现代生物医学进展, 2022, 22(12): 2255-2259. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202212009.htm
    [14]
    奚月, 劣登峰, 魏东. 胸腔闭式引流术后感染患者病原菌分布、危险因素分析及干预措施研究[J]. 临床肺科杂志, 2021, 26(1): 40-44. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFK202101009.htm
    [15]
    杨吉伟, 王丽丽, 宋珺瑶, 等. 心脏死亡器官捐献肾移植术后受者泌尿道感染影响因素及病原学分析[J]. 中华医院感染学杂志, 2020, 30(1): 101-105. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY202001023.htm
    [16]
    PERRIN K, VATS A, QURESHI A, et al. Catheter-associated urinary tract infection (CAUTI) in the NeuroICU: identification of risk factors and time-to-CAUTI using a case-control design[J]. Neurocrit Care, 2021, 34(1): 271-278. doi: 10.1007/s12028-020-01020-3
    [17]
    SHANG P, ZHU M Q, BAKER M, et al. Mechanical ventilation in Guillain-Barré syndrome[J]. Expert Rev Clin Immunol, 2020, 16(11): 1053-1064. doi: 10.1080/1744666X.2021.1840355
    [18]
    张维, 张雅鑫, 冀召帅, 等. 肝移植患者围手术期人血白蛋白临床应用分析[J]. 临床药物治疗杂志, 2020, 18(1): 21-24. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYW202001006.htm
    [19]
    王爱媛, 张婷, 李春双, 等. 糖尿病肾病患者血CD64、Alb、IL-6表达及其与合并肺部感染的关系和预后影响因素[J]. 中国老年学杂志, 2022, 42(3): 547-550. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ202203012.htm
    [20]
    陈伟钢, 张昊, 武文斌, 等. 单向式与常规单孔胸腔镜肺叶切除术后早期拔除胸腔引流管的回顾性队列研究[J]. 中国胸心血管外科临床杂志, 2023, 30(1): 71-77. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXYX202301010.htm
    [21]
    钱春艳, 韩晓霞, 杨楠. 影响留置导尿管患者发生泌尿系统感染的多因素非条件Logistic回归分析[J]. 保健医学研究与实践, 2023, 20(2): 76-80. https://www.cnki.com.cn/Article/CJFDTOTAL-GXBJ202302016.htm
    • Related Articles

  • Related Articles

    [1]ZHU Rong, XIONG Zhaohui, CHEN Yunliang, LI Mengxin, WANG Haiquan. Effect of midazolam and dexmedetomidine in patients with septic shock during mechanical ventilation[J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 124-127. DOI: 10.7619/jcmp.20223579
    [2]ZHU Guanneng, WANG Yang, SONG Haimiao, FENG Erwen. Analysis of risk factors and pathogenic bacteria of ventilator-associated pneumonia in patients with severe trauma undergoing mechanical ventilation in intensive care unit[J]. Journal of Clinical Medicine in Practice, 2022, 26(10): 101-104. DOI: 10.7619/jcmp.20214843
    [3]LU Jun, LIN Qian, ZHANG Dan, HU Hong. Effect of cluster nursing on ventilation time and nursing quality in mechanical ventilation neonates[J]. Journal of Clinical Medicine in Practice, 2020, 24(7): 53-55. DOI: 10.7619/jcmp.202007016
    [4]YANG Xuefeng. Effect of milrinone combined with high frequency ventilation on arterial blood gas index and mechanical ventilation time in neonates with persistent pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2018, (11): 33-35,40. DOI: 10.7619/jcmp.201811009
    [5]TAO Yu. Cluster nursing intervention in prevention of ventilator-associated pneumonia in patients with mechanical ventilation in RICU[J]. Journal of Clinical Medicine in Practice, 2018, (6): 26-29. DOI: 10.7619/jcmp.201806008
    [6]WANG Miao. Effect of mechanical vibration sputum elimination in reducing pulmonary complications in ICU patients with mechanical ventilation after operation[J]. Journal of Clinical Medicine in Practice, 2017, (10): 70-73. DOI: 10.7619/jcmp.201710022
    [7]PAN Jingya, WAN Wenxia, LI Xuemei. Nursing of RICU patients with mechanically ventilated in sequential ventilation critical period[J]. Journal of Clinical Medicine in Practice, 2016, (22): 27-29. DOI: 10.7619/jcmp.201622009
    [8]ZHANG Hong, SHEN Yuhui, CEHN Huaming. The curative effect analysis of nursing intervention on the continuous respiratory mechanical ventilation in treatment for neonatal respiratory failure[J]. Journal of Clinical Medicine in Practice, 2015, (18): 101-104. DOI: 10.7619/jcmp.201518032
    [9]CHEN Haiwei, LIANG Peng, SU Ning, WEN Jianhua, SU Meihua. The value and the influencing factors of modified sputum-sucking method in prevention and treatment of ventilator-associated pneumonia in patients with mechanical ventilation[J]. Journal of Clinical Medicine in Practice, 2015, (14): 27-29,42. DOI: 10.7619/jcmp.201514009
    [10]XIE Youhua, LU Hong, HUANG Chunye. Nursing experience of mechanical ventilation in patients with replacement of mitral valve[J]. Journal of Clinical Medicine in Practice, 2013, (10): 49-51. DOI: 10.7619/jcmp.201310019

  • Cited by

    Periodical cited type(31)

    1. 黄奇峰，郑鹏程，戴燕玲. 二甲双胍、阿卡波糖分别联用厄贝沙坦治疗糖尿病合并高血压的临床效果比较. 糖尿病新世界. 2024(04): 56-59+66 .
    2. 孙燕，张新菊，李雁. 卡格列净在基层糖尿病慢病管理中的疗效观察. 兵团医学. 2024(01): 54-56 .
    3. 黄延峰，钟荣惠. 甘精胰岛素搭配阿卡波糖和二甲双胍对糖尿病控制和氧化应激的影响研究. 现代医学与健康研究电子杂志. 2024(12): 51-54 .
    4. 程继华，孟俊娜，雷巧玲. 艾塞那肽治疗2型糖尿病的疗效及对胰岛素抵抗与糖脂代谢的影响研究. 中国医学工程. 2024(08): 88-92 .
    5. 贾志壮. 阿卡波糖联合二甲双胍治疗2型糖尿病的效果. 名医. 2024(09): 165-167 .
    6. 黄伟玲. 阿卡波糖联合二甲双胍治疗2型糖尿病对免疫功能及不良反应的影响. 临床合理用药. 2024(28): 103-105+115 .
    7. 任喆. 阿卡波糖联合二甲双胍在社区糖尿病患者糖代谢控制中的应用效果. 中国社区医师. 2024(32): 26-28 .
    8. 张秀丽，余玉花，张文帝. 二甲双胍联合阿卡波糖对2型糖尿病患者免疫功能、糖脂代谢的影响. 糖尿病新世界. 2024(18): 86-88+92 .
    9. 林钧，陈玮，刘进清. 视网膜激光光凝术与阿卡波糖联合治疗糖尿病性黄斑水肿的临床疗效. 糖尿病新世界. 2024(23): 187-190 .
    10. 岳斌，张巍，徐丽，郑华东，李明. 二甲双胍联合阿卡波糖治疗2型糖尿病的疗效及对免疫功能和NLRP3水平的影响. 海南医学. 2023(01): 14-18 .
    11. 耿瑶. 探究达格列净治疗2型糖尿病并心衰的临床疗效及其对炎性因子、血管内皮功能的影响. 黑龙江医学. 2023(05): 547-550 .
    12. 王鑫. 阿卡波糖联合二甲双胍治疗2型糖尿病的临床疗效观察. 现代诊断与治疗. 2023(01): 64-66+69 .
    13. 卢洁菲. 阿卡波糖联合二甲双胍对2型糖尿病患者免疫功能及炎性因子的影响. 甘肃医药. 2023(04): 318-319+325 .
    14. 景珊. 二甲双胍联合阿卡波糖用于糖尿病治疗的疗效及对HbA1c、FPG水平的影响分析. 糖尿病新世界. 2023(09): 76-79 .
    15. 孙嘉婧，于湘英，马子良. 阿卡波糖与二甲双胍在社区糖尿病治疗中的效果及对血糖的影响探析. 糖尿病新世界. 2023(10): 108-111+115 .
    16. 卢凯丽，宋瑞捧，姜惠惠，高红红. 阿卡波糖联合维格列汀治疗初治2型糖尿病的效果及对糖脂代谢的影响. 中国实用医刊. 2023(14): 109-112 .
    17. 方信英. 二甲双胍联合阿卡波糖在2型糖尿病患者中的应用效果分析. 糖尿病新世界. 2023(23): 81-84 .
    18. 仲伟慧. 阿卡波糖联合二甲双胍治疗2型糖尿病的疗效分析. 中国社区医师. 2022(06): 76-77+80 .
    19. 刘燕君，朱明敏，陈亚东. 二甲双胍与预混胰岛素联用对2型糖尿病患者血糖指标水平与不良反应的影响. 糖尿病新世界. 2022(05): 68-71 .
    20. 刘婷，王莹，杨召娣，陈继芳. 阿卡波糖联合二甲双胍治疗2型糖尿病对患者血糖水平、胰岛功能的影响. 现代医学与健康研究电子杂志. 2022(12): 142-144 .
    21. 王云枫，王彦贺. 阿卡波糖对2型糖尿病患者血脂及尿酸代谢的影响. 哈尔滨医药. 2022(03): 62-63 .
    22. 王学光. 二甲双胍联合阿卡波糖治疗2型糖尿病临床疗效分析. 糖尿病新世界. 2022(11): 102-105 .
    23. 陈聪，梁黎黎. 有氧-抗阻运动指导联合降糖药物对老年糖尿病患者的应用效果. 现代医学与健康研究电子杂志. 2022(21): 141-144 .
    24. 张建，范文文. DPP-4抑制剂联合阿卡波糖治疗初诊老年T2DM患者的疗效分析. 国际医药卫生导报. 2022(23): 3388-3391 .
    25. 黄文新. 瑞格列奈结合二甲双胍治疗2型糖尿病的疗效及对患者血糖水平的影响. 糖尿病新世界. 2021(07): 87-89 .
    26. 阳玲，黄冠军，方涛，柴振华，朱红艳. 二甲双胍联合阿格列汀或阿卡波糖治疗2型糖尿病的疗效对比. 药品评价. 2021(10): 621-623 .
    27. 徐露，章晓君. 阿卡波糖联合二甲双胍治疗糖尿病前期患者的效果分析. 现代医学与健康研究电子杂志. 2021(15): 51-53 .
    28. 房思思，屈桂茹. 拜糖平和二甲双胍治疗2型糖尿病的有效性及安全性研究. 中国药物滥用防治杂志. 2021(05): 682-684+703 .
    29. 周芸，刘路. 阿卡波糖联合二甲双胍对2型糖尿病患者血糖与肠促胰岛素水平的影响. 现代医学与健康研究电子杂志. 2021(18): 45-47 .
    30. 李黎，张瑞. 阿卡波糖联合二甲双胍用于治疗2型糖尿病临床效果分析. 世界复合医学. 2021(10): 195-198 .
    31. 宋先梅. 二甲双胍结合阿卡波糖治疗初发2型糖尿病伴高脂血症的临床效果分析. 中国现代药物应用. 2021(23): 139-141 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (129) PDF downloads (10) Cited by(31)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return